KORU Medical Systems, Inc. (KRMD)
USD 3.7
(-10.19%)
USD 3.7
(-10.19%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -13.74 Million USD | -58.65% |
| 2022 | -8.66 Million USD | -89.82% |
| 2021 | -4.56 Million USD | -276.45% |
| 2020 | -1.21 Million USD | -314.77% |
| 2019 | 564.34 Thousand USD | -38.02% |
| 2018 | 910.57 Thousand USD | -16.15% |
| 2017 | 1.08 Million USD | 302.98% |
| 2016 | -534.99 Thousand USD | -168.34% |
| 2015 | 782.86 Thousand USD | 3.95% |
| 2014 | 753.11 Thousand USD | 7.06% |
| 2013 | 703.42 Thousand USD | -3.08% |
| 2012 | 725.76 Thousand USD | -11.05% |
| 2011 | 815.89 Thousand USD | 15.88% |
| 2010 | 704.08 Thousand USD | -20.84% |
| 2009 | 889.44 Thousand USD | -13.72% |
| 2008 | 1.03 Million USD | 41350.7% |
| 2007 | -2499.00 USD | 99.02% |
| 2006 | -254.72 Thousand USD | -16.94% |
| 2005 | -217.81 Thousand USD | 45.67% |
| 2004 | -400.89 Thousand USD | -44.21% |
| 2003 | -277.99 Thousand USD | -3.66% |
| 2002 | -268.19 Thousand USD | 30.53% |
| 2001 | -386.07 Thousand USD | -269.6% |
| 2000 | -104.45 Thousand USD | -141.73% |
| 1999 | 250.3 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -988.71 Thousand USD | 48.93% |
| 2024 Q1 | -1.93 Million USD | 74.07% |
| 2023 FY | -13.74 Million USD | -58.65% |
| 2023 Q3 | -1.36 Million USD | 45.18% |
| 2023 Q2 | -2.49 Million USD | -3.53% |
| 2023 Q4 | -7.46 Million USD | -445.66% |
| 2023 Q1 | -2.41 Million USD | -21.96% |
| 2022 Q4 | -1.97 Million USD | -61.29% |
| 2022 Q2 | -2.92 Million USD | -15.13% |
| 2022 Q3 | -1.22 Million USD | 58.05% |
| 2022 Q1 | -2.53 Million USD | -137.52% |
| 2022 FY | -8.66 Million USD | -89.82% |
| 2021 FY | -4.56 Million USD | -276.45% |
| 2021 Q1 | -1.27 Million USD | -52.9% |
| 2021 Q2 | -1.12 Million USD | 11.88% |
| 2021 Q4 | -1.06 Million USD | 2.32% |
| 2021 Q3 | -1.09 Million USD | 2.74% |
| 2020 FY | -1.21 Million USD | -314.77% |
| 2020 Q3 | 249.17 Thousand USD | 123.16% |
| 2020 Q4 | -834.62 Thousand USD | -434.96% |
| 2020 Q1 | 449.42 Thousand USD | 659.99% |
| 2020 Q2 | -1.07 Million USD | -339.42% |
| 2019 Q4 | -80.25 Thousand USD | -112.31% |
| 2019 FY | 564.34 Thousand USD | -38.02% |
| 2019 Q3 | 651.81 Thousand USD | 733.7% |
| 2019 Q2 | 78.18 Thousand USD | 191.56% |
| 2019 Q1 | -85.39 Thousand USD | 75.96% |
| 2018 Q3 | 386.55 Thousand USD | -18.74% |
| 2018 FY | 910.57 Thousand USD | -16.15% |
| 2018 Q4 | -355.13 Thousand USD | -191.87% |
| 2018 Q1 | 403.42 Thousand USD | -25.95% |
| 2018 Q2 | 475.72 Thousand USD | 17.92% |
| 2017 Q4 | 544.77 Thousand USD | 104.99% |
| 2017 Q2 | 148.47 Thousand USD | 229.34% |
| 2017 Q1 | -114.79 Thousand USD | -10.09% |
| 2017 FY | 1.08 Million USD | 302.98% |
| 2017 Q3 | 265.75 Thousand USD | 78.99% |
| 2016 FY | -534.99 Thousand USD | -168.34% |
| 2016 Q1 | 344.73 Thousand USD | 105.75% |
| 2016 Q4 | -104.27 Thousand USD | -26.22% |
| 2016 Q3 | -82.61 Thousand USD | 64.59% |
| 2016 Q2 | -233.31 Thousand USD | -167.68% |
| 2015 Q4 | 167.55 Thousand USD | -50.02% |
| 2015 Q3 | 335.21 Thousand USD | 618.59% |
| 2015 Q2 | -64.64 Thousand USD | -121.59% |
| 2015 Q1 | 299.37 Thousand USD | 222.98% |
| 2015 FY | 782.86 Thousand USD | 3.95% |
| 2014 Q3 | 202.99 Thousand USD | 28.43% |
| 2014 Q4 | 92.69 Thousand USD | -54.34% |
| 2014 FY | 753.11 Thousand USD | 7.06% |
| 2014 Q1 | 377.41 Thousand USD | 133.04% |
| 2014 Q2 | 158.05 Thousand USD | -58.12% |
| 2013 Q4 | 161.95 Thousand USD | 78.54% |
| 2013 Q2 | 73.35 Thousand USD | -68.0% |
| 2013 FY | 703.42 Thousand USD | -3.08% |
| 2013 Q1 | 229.25 Thousand USD | 312.9% |
| 2013 Q3 | 90.7 Thousand USD | 23.66% |
| 2012 Q2 | 90.33 Thousand USD | -71.56% |
| 2012 Q4 | 55.52 Thousand USD | -84.17% |
| 2012 Q3 | 350.64 Thousand USD | 288.14% |
| 2012 FY | 725.76 Thousand USD | -11.05% |
| 2012 Q1 | 317.61 Thousand USD | 74.28% |
| 2011 FY | 815.89 Thousand USD | 15.88% |
| 2011 Q1 | 346.28 Thousand USD | 105.94% |
| 2011 Q2 | 197.95 Thousand USD | -42.83% |
| 2011 Q3 | 118.07 Thousand USD | -40.35% |
| 2011 Q4 | 182.24 Thousand USD | 54.35% |
| 2010 Q2 | 88.42 Thousand USD | -86.59% |
| 2010 FY | 704.08 Thousand USD | -20.84% |
| 2010 Q4 | 168.14 Thousand USD | 66.1% |
| 2010 Q1 | 659.29 Thousand USD | 1088.24% |
| 2010 Q3 | 101.23 Thousand USD | 14.49% |
| 2009 Q4 | 55.48 Thousand USD | -49.84% |
| 2009 FY | 889.44 Thousand USD | -13.72% |
| 2009 Q1 | 495.39 Thousand USD | 158.97% |
| 2009 Q3 | 110.61 Thousand USD | 72.69% |
| 2009 Q2 | 64.05 Thousand USD | -87.07% |
| 2008 Q2 | 64.78 Thousand USD | 2.36% |
| 2008 Q1 | 63.29 Thousand USD | 3.15% |
| 2008 FY | 1.03 Million USD | 41350.7% |
| 2008 Q4 | 191.29 Thousand USD | -31.57% |
| 2008 Q3 | 279.52 Thousand USD | 331.48% |
| 2007 FY | -2499.00 USD | 99.02% |
| 2007 Q3 | 54.36 Thousand USD | 130.45% |
| 2007 Q4 | 61.35 Thousand USD | 12.86% |
| 2007 Q2 | -178.52 Thousand USD | -707.44% |
| 2007 Q1 | 29.38 Thousand USD | 143.41% |
| 2006 Q1 | -98.08 Thousand USD | -239.28% |
| 2006 Q3 | -89.14 Thousand USD | 57.0% |
| 2006 Q4 | -67.69 Thousand USD | 24.07% |
| 2006 FY | -254.72 Thousand USD | -16.94% |
| 2006 Q2 | -207.31 Thousand USD | -111.37% |
| 2005 Q2 | -145.92 Thousand USD | 22.42% |
| 2005 FY | -217.81 Thousand USD | 45.67% |
| 2005 Q4 | 70.42 Thousand USD | 259.21% |
| 2005 Q3 | -44.23 Thousand USD | 69.69% |
| 2005 Q1 | -188.08 Thousand USD | -54.7% |
| 2004 FY | -400.89 Thousand USD | -44.21% |
| 2004 Q2 | 1041.00 USD | 101.02% |
| 2004 Q3 | -92.26 Thousand USD | -8962.73% |
| 2004 Q4 | -121.58 Thousand USD | -31.78% |
| 2004 Q1 | -101.71 Thousand USD | -34.01% |
| 2003 Q1 | -165.44 Thousand USD | -462.44% |
| 2003 FY | -277.99 Thousand USD | -3.66% |
| 2003 Q4 | -75.9 Thousand USD | -6.16% |
| 2003 Q3 | -71.49 Thousand USD | -147.48% |
| 2003 Q2 | -28.88 Thousand USD | 82.54% |
| 2002 FY | -268.19 Thousand USD | 30.53% |
| 2002 Q4 | -29.41 Thousand USD | -64.47% |
| 2002 Q3 | -17.88 Thousand USD | 64.36% |
| 2002 Q2 | -50.17 Thousand USD | 55.49% |
| 2002 Q1 | -112.73 Thousand USD | -11.67% |
| 2001 Q1 | -122.14 Thousand USD | -576.28% |
| 2001 FY | -386.07 Thousand USD | -269.6% |
| 2001 Q4 | -100.94 Thousand USD | -57.92% |
| 2001 Q3 | -63.92 Thousand USD | 41.07% |
| 2001 Q2 | -108.46 Thousand USD | 11.2% |
| 2000 FY | -104.45 Thousand USD | -141.73% |
| 2000 Q2 | 10.2 Thousand USD | 0.0% |
| 2000 Q4 | -18.06 Thousand USD | -170.7% |
| 2000 Q3 | 25.54 Thousand USD | 150.39% |
| 1999 FY | 250.3 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -63.32 Million USD | 78.3% |
| AngioDynamics, Inc. | -184.34 Million USD | 92.546% |
| AtriCure, Inc. | -30.43 Million USD | 54.856% |
| Avinger, Inc. | -18.32 Million USD | 24.994% |
| Azenta, Inc. | -14.25 Million USD | 3.619% |
| BioLife Solutions, Inc. | -66.42 Million USD | 79.314% |
| The Cooper Companies, Inc. | 294.2 Million USD | 104.671% |
| Daxor Corporation | 280.64 Thousand USD | 4996.331% |
| Ekso Bionics Holdings, Inc. | -15.19 Million USD | 9.586% |
| Femasys Inc. | -14.24 Million USD | 3.552% |
| GlucoTrack, Inc. | -7.09 Million USD | -93.618% |
| Harvard Bioscience, Inc. | -3.41 Million USD | -302.374% |
| Hologic, Inc. | 789.5 Million USD | 101.74% |
| ICU Medical, Inc. | -29.65 Million USD | 53.664% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | 100.764% |
| LeMaitre Vascular, Inc. | 30.1 Million USD | 145.644% |
| Innovative Eyewear, Inc. | -6.66 Million USD | -106.216% |
| Innovative Eyewear, Inc. | -6.66 Million USD | -106.216% |
| Masimo Corporation | 81.5 Million USD | 116.86% |
| Microbot Medical Inc. | -10.74 Million USD | -27.943% |
| Meihua International Medical Technologies Co., Ltd. | 11.62 Million USD | 218.198% |
| Merit Medical Systems, Inc. | 94.41 Million USD | 114.555% |
| Nephros, Inc. | -1.57 Million USD | -772.448% |
| NovoCure Limited | -207.04 Million USD | 93.363% |
| NEXGEL, Inc. | -3.15 Million USD | -335.257% |
| NEXGEL, Inc. | -3.15 Million USD | -335.257% |
| Singular Genomics Systems, Inc. | -94.82 Million USD | 85.508% |
| OraSure Technologies, Inc. | 53.65 Million USD | 125.61% |
| Pro-Dex, Inc. | 2.12 Million USD | 746.03% |
| Pulse Biosciences, Inc. | -42.21 Million USD | 67.446% |
| Predictive Oncology Inc. | -13.98 Million USD | 1.737% |
| Precision Optics Corporation, Inc. | -2.95 Million USD | -365.581% |
| QuidelOrtho Corporation | -10.1 Million USD | -36.05% |
| Repligen Corporation | 41.57 Million USD | 133.05% |
| Sanara MedTech Inc. | -4.3 Million USD | -219.322% |
| STAAR Surgical Company | 21.34 Million USD | 164.37% |
| Sharps Technology, Inc. | -9.84 Million USD | -39.622% |
| Utah Medical Products, Inc. | 16.63 Million USD | 182.603% |
| DENTSPLY SIRONA Inc. | -132 Million USD | 89.59% |
| Jin Medical International Ltd. | 2.87 Million USD | 577.414% |